Clinical Trial Update: Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating cyclodextrin as a novel anti-tussive therapy for cough was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• cyclodextrin (cyclodextrin)

Snippet

Sponsor: Imperial College London | Conditions: Cough | Phase 4 | Status: WITHDRAWN